Skip to main content Accessibility help
×
Home
Hostname: page-component-dc8c957cd-shgcr Total loading time: 0.377 Render date: 2022-01-26T16:08:20.583Z Has data issue: false Feature Flags: { "shouldUseShareProductTool": true, "shouldUseHypothesis": true, "isUnsiloEnabled": true, "metricsAbstractViews": false, "figures": true, "newCiteModal": false, "newCitedByModal": true, "newEcommerce": true, "newUsageEvents": true }

The Therapeutic Value of Lysergic Acid Diethylamide in Mental Illness

Published online by Cambridge University Press:  08 February 2018

J. D. A. Whitelaw
Affiliation:
Powick Mental Hospital, near Worcester

Extract

D-lysergic acid diethylamide (LSD 25) was first prepared in 1938 by Stoll and Hofmann. It is the synthetic amide of d-lysergic acid with a secondary amine, diethylamine and belongs to the ergonovine group of ergot alkaloids all of which have lysergic acid as a base. After its ingestion in minute doses, it induces psychic states in which the subject becomes aware of repressed memories and other unconscious material in a setting of clear consciousness. This preliminary paper describes the results obtained from the use of the drug in 36 psychoneurotic patients over a period of one year. We consider that the drug will find a significant place in the treatment of the psychoneuroses and allied mental illnesses.

Type
Original Articles
Copyright
Copyright © Royal College of Psychiatrists, 1954 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Ashby, W. R., Design for a Brain, 1952. London, Chapman and Hall.Google Scholar
Becker, A. M., Wien. Z. Nervenhk., 1949, 2, 402.Google Scholar
Busch, A. K., and Johnson, W. C., Dis. Nerv. System, 1950, 11, 241.Google Scholar
Condrau, G., Acta. psych. neurol. Scand., 1949, 24, 9.CrossRefGoogle Scholar
DeShon, H. J., Rinkel, M., and Solomon, H. C., Psychiat. Quart., 1952, 26, 33.CrossRefGoogle Scholar
Elkes, J., Personal communication, 1953.Google Scholar
Fischer, R., Georgi, F., and Weber, R., Schweiz. med. Wschr., 1951, 81, 817 and 837.Google Scholar
Gastaut, H., Ferrer, S., Castells, C., et al., Confin. Neurol., 1953, 13, 103.CrossRefGoogle Scholar
de Giacomo, U., Acta neurol. (Ital.), 1951, 6, No. 1.Google Scholar
Matefi, L., Confin. Neurol., 1952, 12, 146.CrossRefGoogle Scholar
Mayer-Gross, W., McAdam, W., and Walker, J., Nervenarzt., 1952, 23, 30.Google Scholar
Stockings, G. T., J. Ment. Sci., 1940, 86, 29.CrossRefGoogle Scholar
Stoll, W. A., Schweiz. Archiv. f. Neurol. u. Psychiat., 1947, 60, 1.Google Scholar
Idem, Schweiz. med. Wschr., 1949, 79, 110.Google Scholar
Weyl, B., Diss. der. Medizinischen. Fakultät der Universität Freiburg im Br., 1951.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.
91
Cited by

Send article to Kindle

To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

The Therapeutic Value of Lysergic Acid Diethylamide in Mental Illness
Available formats
×

Send article to Dropbox

To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

The Therapeutic Value of Lysergic Acid Diethylamide in Mental Illness
Available formats
×

Send article to Google Drive

To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

The Therapeutic Value of Lysergic Acid Diethylamide in Mental Illness
Available formats
×
×

Reply to: Submit a response

Please enter your response.

Your details

Please enter a valid email address.

Conflicting interests

Do you have any conflicting interests? *